Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Oblique Therapeutics AB (publ)

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 5 More Arrow 183 Less Arrow 27
Earnings before taxes -5,581 More Arrow -4,812 Less Arrow -6,027
EBITDA -3,403 Less Arrow -4,334 Less Arrow -5,695
Total assets 1,673 Less Arrow 1,633 More Arrow 3,015
Current assets 1,457 Less Arrow 729 More Arrow 2,181
Current liabilities 552 More Arrow 1,012 Less Arrow 934
Equity capital 1,044 Less Arrow 302 More Arrow 1,929
- share capital 165 Less Arrow 68 More Arrow 74
Employees (average) 18 Equal arrow 18 Less Arrow 16

Financial ratios

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 62.4% Less Arrow 18.5% More Arrow 64.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -333.3% More Arrow -283.5% More Arrow -199.0%
Current ratio 263.9% Less Arrow 72.0% More Arrow 233.5%
Return on equity (ROE) -534.6% Less Arrow -1593.4% More Arrow -312.4%
Change turnover
Change turnover % -100%
Chg. No. of employees
Chg. No. of employees % 13% More Arrow 33%

Total value of public sale

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.